-
ADPD 2024: A Global Gathering of Neurology Experts
Accelsiors continues to support ADPD, with our attendance at this year’s conference in Lisbon, in March 2024! ADPD 2024, brought together esteemed colleagues, investigators, and partners from around the world. The conference provided a platform for experts to showcase groundbreaking research, discuss recent challenges, and explore innovative solutions in the fields of Alzheimer’s and Parkinson’s…
-
Accelsiors Webinar: Running Clinical Trials in Europe
On March 14th, 2024 at 18:00 CET, Accelsiors is hosting an exclusive webinar on Key Regulatory & Legal Requirements for Running Clinical Trials in Europe. This webinar is tailored for Regulatory, Compliance, and Legal professionals within Life Science & Biotechnology companies planning to run clinical trials in the EU. It is a great opportunity to…
-
Navigating the New Swiss Privacy Regime: Implications for Clinical Trials
The revised Swiss Federal Act on Data Protection (FADP) went into effectiveness September 1, 2023, and it poses significant challenges for clinical trials. The new law applies not only to trials conducted in Switzerland but also to any data processing operations within the country. It introduces severe sanctions for individuals responsible for infringements, mandates immediate…
-
Accelsiors at ESMO Congress 2023
ESMO 2023 brings together researchers, clinicians, scientists and healthcare market leaders from all over the world. The congress hosts the latest cutting-edge data, high-quality education, and innovations on the field. Accelsiors is deeply involved in the field of oncology (breast, ovarian, renal cancer, melanoma etc), and our team has designed and executed numerous trials in the…
-
Our New US Office!
We are marking an exciting, new milestone with the opening of Accelsiors’ Los Angeles office – a significant step in our journey to bring our services closer to our clients & partners. This investment reflects our deep commitment to our valued clients in the US. By establishing a local presence, we’re dedicated to providing tailored…
-
Accelsiors has joined BioCom California!
Accelsiors has joined Biocom California! This marks our dedicated focus on the US market, reinforcing our commitment with strategic investments. Thrilled to be part of this dynamic community. You can find more about our mission and values. Learn more about us. We know. We care. We support.
-
Accelsiors at AAIC23
Accelsiors’ team attended the #AAIC2023! The latest evolution and clinical research results were published at the Alzheimer’s Association International Conference (AAIC) in Amsterdam. Our team was there, strengthening connections with scientists and clients, with a strong belief for a bright future of Alzheimer’s clinical research. After-conference conclusions Many promising findings for the Alzheimer…
